FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)


57868 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
Anterior vitrectomy Preferred (foundation metadata concept)
Anterior vitrectomy (procedure) Preferred (foundation metadata concept)
Anterior wall of urinary bladder Acceptable (foundation metadata concept)
Anterior wall of vagina Acceptable (foundation metadata concept)
Anterograde amnesia Preferred (foundation metadata concept)
Anterograde amnesia (finding) Preferred (foundation metadata concept)
Anteroposterior abnormal curvature Preferred (foundation metadata concept)
Anteroposterior abnormal curvature (morphologic abnormality) Preferred (foundation metadata concept)
Anteversion Preferred (foundation metadata concept)
Anteversion (morphologic abnormality) Preferred (foundation metadata concept)
Anthelmintic Preferred (foundation metadata concept)
Anthelmintic (disposition) Preferred (foundation metadata concept)
Anthracene Preferred (foundation metadata concept)
Anthracene (substance) Preferred (foundation metadata concept)
Anthralin Preferred (foundation metadata concept)
Anthraquinone Preferred (foundation metadata concept)
Anthraquinone (substance) Preferred (foundation metadata concept)
Anthrax Preferred (foundation metadata concept)
Anthrax (disorder) Preferred (foundation metadata concept)
Anthrax bacillus Acceptable (foundation metadata concept)
Anthrax vaccine Acceptable (foundation metadata concept)
Anti HCV measurement Acceptable (foundation metadata concept)
Anti human globulin test Acceptable (foundation metadata concept)
Anti human globulin test technique Acceptable (foundation metadata concept)
Anti human globulin test technique (qualifier value) Preferred (foundation metadata concept)
Anti human globulin test technique, direct Acceptable (foundation metadata concept)
Anti human globulin test technique, direct (qualifier value) Preferred (foundation metadata concept)
Anti human globulin test, direct Acceptable (foundation metadata concept)
Anti-beriberi factor Acceptable (foundation metadata concept)
Anti-infective agent Preferred (foundation metadata concept)
Anti-infective agent (substance) Preferred (foundation metadata concept)
Anti-infectives Acceptable (foundation metadata concept)
Anti-nuclear antibody level Acceptable (foundation metadata concept)
Anti-nuclear antibody measurement Acceptable (foundation metadata concept)
Anti-nuclear antibody positive Acceptable (foundation metadata concept)
Anti-nuclear factor detected Preferred (foundation metadata concept)
Anti-nuclear factor detected (finding) Preferred (foundation metadata concept)
Anti-nuclear factor positive Acceptable (foundation metadata concept)
Anti-phospholipid antibody Preferred (foundation metadata concept)
Anti-phospholipid autoantibody Acceptable (foundation metadata concept)
Anti-phospholipid autoantibody (substance) Preferred (foundation metadata concept)
Anti-psychotic agent Preferred (foundation metadata concept)
Anti-psychotic agent (substance) Preferred (foundation metadata concept)
Antianemia agent Acceptable (foundation metadata concept)
Antibacterial Preferred (foundation metadata concept)
Antibacterial Preferred (foundation metadata concept)
Antibacterial (disposition) Preferred (foundation metadata concept)
Antibacterial agent resistant bacteria Acceptable (foundation metadata concept)
Antibacterial therapeutic role Preferred (foundation metadata concept)
Antibacterial therapeutic role (role) Preferred (foundation metadata concept)
Antibody Preferred (foundation metadata concept)
Antibody (substance) Preferred (foundation metadata concept)
Antibody to 2019 novel coronavirus Acceptable (foundation metadata concept)
Antibody to 2019-nCoV Acceptable (foundation metadata concept)
Antibody to Coronavirus Acceptable (foundation metadata concept)
Antibody to Coronavirus (substance) Preferred (foundation metadata concept)
Antibody to Helicobacter pylori Acceptable (foundation metadata concept)
Antibody to Helicobacter pylori (substance) Preferred (foundation metadata concept)
Antibody to Hepatitis A virus Acceptable (foundation metadata concept)
Antibody to Hepatitis A virus (substance) Preferred (foundation metadata concept)
Antibody to Hepatitis B core antigen Acceptable (foundation metadata concept)
Antibody to Hepatitis B core antigen (substance) Preferred (foundation metadata concept)
Antibody to Hepatitis B virus surface antigen Acceptable (foundation metadata concept)
Antibody to Hepatitis B virus surface antigen (substance) Preferred (foundation metadata concept)
Antibody to Hepatitis C virus Acceptable (foundation metadata concept)
Antibody to Hepatitis C virus (substance) Preferred (foundation metadata concept)
Antibody to SARS-CoV-2 Acceptable (foundation metadata concept)
Antibody to antigen in ISBT system 004 Acceptable (foundation metadata concept)
Antibody to antigen in ISBT system RH Acceptable (foundation metadata concept)
Antibody to antigen in Rh blood group system Preferred (foundation metadata concept)
Antibody to antigen in Rh blood group system (substance) Preferred (foundation metadata concept)
Antibody to severe acute respiratory syndrome coronavirus 2 Acceptable (foundation metadata concept)
Antibody to severe acute respiratory syndrome coronavirus 2 (substance) Preferred (foundation metadata concept)
Antibody-mediated activation and inactivation Preferred (foundation metadata concept)
Antibody-mediated activation and inactivation (disorder) Preferred (foundation metadata concept)
Anticardiolipin syndrome Acceptable (foundation metadata concept)
Anticoagulant Preferred (foundation metadata concept)
Anticoagulant (substance) Preferred (foundation metadata concept)
Anticoagulant adverse reaction Preferred (foundation metadata concept)
Anticoagulant adverse reaction (disorder) Preferred (foundation metadata concept)
Anticoagulant poisoning Acceptable (foundation metadata concept)
Anticoagulant therapy Preferred (foundation metadata concept)
Anticoagulant therapy (procedure) Preferred (foundation metadata concept)
Anticonvulsant hypersensitivity syndrome Acceptable (foundation metadata concept)
Anticonvulsant therapeutic role Preferred (foundation metadata concept)
Anticonvulsant therapeutic role (role) Preferred (foundation metadata concept)
Antidepressant Preferred (foundation metadata concept)
Antidepressant (substance) Preferred (foundation metadata concept)
Antidote Preferred (foundation metadata concept)
Antidote (substance) Preferred (foundation metadata concept)
Antiemetic therapeutic role Preferred (foundation metadata concept)
Antiemetic therapeutic role (role) Preferred (foundation metadata concept)
Antifungal Preferred (foundation metadata concept)
Antifungal (disposition) Preferred (foundation metadata concept)
Antifungal agent resistant fungi Acceptable (foundation metadata concept)
Antigen of 2019 novel coronavirus Acceptable (foundation metadata concept)
Antigen of 2019-nCoV Acceptable (foundation metadata concept)
Antigen of Adenovirus Acceptable (foundation metadata concept)
Antigen of Adenovirus (substance) Preferred (foundation metadata concept)
Antigen of Alternaria alternata protein Acceptable (foundation metadata concept)
Antigen of Alternaria alternata protein (substance) Preferred (foundation metadata concept)

Start Previous Page 32 of 579 Next End


Reference Sets

Reference set descriptor

Back to Start